← Open Payments lookup

SHREEKUMAR VINEKAR: Open Payments

NPI 1396713640 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$718 in 35 payments from 9 companies in 2025. Trend: 2023 $1,968 · 2024 $336 · 2025 $718

Food & beverage: $718
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$269
Alkermes, Inc.7$136
Almatica Pharma LLC4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64
ABBVIE INC.2$48
Teva Pharmaceuticals USA, Inc.2$45
IDORSIA PHARMACEUTICALS US INC1$23
Supernus Pharmaceuticals, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$19

Products named: REXULTI, ARISTADA, LOREEV XR, CAPLYTA, VRAYLAR, AUSTEDO XR, ABILIFY ASIMTUFII, Quviviq.

Industry payments across OK — which companies pay providers there.